Drug intelligence / Profile preview

heterologous type I collagen

Development stage
Unknown
Lead developer
CSD
Modality
Recombinant Proteins and Enzymes
Administration
Intradermal, Topical
01

Overview

**Heterologous type I collagen** is a purified collagen product derived from non-human animal sources, commonly equine (horse) tendon, and used for biomedical, pharmaceutical, and cosmetic applications, primarily as a regenerative biomaterial and injectable medical device[1][3][4]. It acts as a substrate for cell adhesion, growth, and differentiation of connective tissue cells, promoting fibroblast proliferation, extracellular matrix (ECM) reconstruction, and facilitating physiological neoformation of human collagen. Its main clinical applications include the management of skin aging (biorevitalization), treatment of connective tissue injuries, and as an adjunct in therapies for disorders such as vitiligo, where it may enhance repigmentation by stimulating melanogenesis and ECM repair[3][4]. Products such as Linerase use sterile, pyrogen-free equine-derived type I collagen for intradermal injections, typically administered by healthcare professionals in protocols that include repeated sessions[3]. Mechanistically, it supports tissue regeneration, modulates local inflammatory response, and provides a scaffold for new ECM synthesis[1][4].

Brand names
Linerase
Other names
HTIC
02

Targets

MC1R (Melanocortin Type 1 Receptor)

Beyond the preview

Go deeper on heterologous type I collagen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on heterologous type I collagen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call